Skip to main content
Loading

Halia Therapeutics

February 10, 2025
Inflammation
Halia Therapeutics
Recognizing the link between inflammation and numerous chronic diseases, including Alzheimer’s, cardiovascular disease, cancer, and various disorders of the skin, intestines, and liver, Halia expanded its vision. The company is pioneering a method to disrupt chronic inflammation through a specific inflammatory pathway, potentially treating many diseases
Speakers
David Bearss, CEO - Halia Therapeutics
View all 2025 Program
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP